Allogene Therapeutics
ALLO
ALLO
173 hedge funds and large institutions have $402M invested in Allogene Therapeutics in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
12% more funds holding
Funds holding: 155 → 173 (+18)
11.37% more ownership
Funds ownership: 78.61% → 89.98% (+11%)
13% less capital invested
Capital invested by funds: $460M → $402M (-$58.5M)
Holders
173
Holding in Top 10
4
Calls
$446K
Puts
$176K
Top Buyers
| 1 | +$9.95M | |
| 2 | +$3.17M | |
| 3 | +$1.77M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.71M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.24M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$7.63M | |
| 3 | -$4.58M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$1.58M |
| 5 |
Morgan Stanley
New York
|
-$1.54M |